Keywords
common variable immunodeficiency
How to Cite
Abstract
The coexistence of primary immunodeficiencies and autoimmune diseases, although contradictory, may occur in clinical practice. These cases pose an important therapeutic challenge due to the risk of infection after immunosuppressive therapy. We report the first case of SLE, lupus nephritis and common variable immunodeficiency successfully treated with cyclophosphamide and intravenous immunoglobulin, without any severe infections.
References
( 1) Gutierrez MJ, Sullivan KE, Fuleihan R, Bingham CO. Phenotypic characterization of patients with rheumatologic manifestations of common variable immunodeficiency. Semin Arthritis Rheum. 2018;48:318-26. https://doi.org/10.1016/j.semarthrit.2018.02.013
(2) Schmidt RE, Grimbacher B, Witte T. Autoimmunity and primary immunodeficiency: two sides of the same coin?. Nat Rev Rheumatol. 2018;14:7-18. http:// dx.doi.org/10.1038/nrrheum.2017.198
(3) Cunningham-Rundles C. Pathogenesis of common variable immunodeficiency. http://www.uptodate.com, accessed July 19, 2019.
(4) Reddy V, Martínez L, Isenberg DA, Leandro MJ, Cambridge G. Pragmatic treatment of patients with Systemic Lupus Erythema- tosus with rituximab: long-term effects on serum immunoglobulins. Arthritis Care Res (Hoboken). 2017;69:857-66. DOI:10.1002/acr. 22993.
(5) Geneviéve M, Bonnet F, Michaux C, Geffroy CE, Vandenhende MA, Combe C, et al. Néphropathie lupique liée à un déficit immunitaire commun variable d’évolution favorable sous immu- noglobulines intraveineuses. Rev Med Interne 2012; 33:31-3. DOI: 10.1016/j.revmed.2011.05.002
(6) Fernández-Castro M, Mellor-Pita S, Citores MJ, Muñoz P, Tutor- Ureta P, Silva L, et al. Common variable immunodeficiency in systemic lupus erythematosus. Semin Arthritis Rheum. 2007;36:238-45. DOI:10.1016/j.semarthrit.2006.09.005